Keisuke Kamisako

1PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 19, 2024
Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real-World Evidence.

Yuta Yamanaka, Yukiko Okuno, Keisuke Kamisako

Pageof 1

Frequent Collaborators

1 joint publications

Yuta Yamanaka

1 joint publications

Yukiko Okuno

1 joint publications

Yuta Okazaki

1 joint publications

Kentaro Nakanishi

1 joint publications

Yume Sanada

1 joint publications

Kiyori Yoshida

1 joint publications

Tatsuki Ikoma

1 joint publications

Yuki Takeyasu

1 joint publications

Utae Katsushima

1 joint publications

Hiroshige Yoshioka

Frequent Collaborators

1 joint publications

Yuta Yamanaka

1 joint publications

Yukiko Okuno

1 joint publications

Yuta Okazaki

1 joint publications

Kentaro Nakanishi

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos